Liaoning Provincial Development and Reform Commission appropriated funds of the central budget for the three-year action plan for emerging industries to Sinqi Ophthalmic Medications for the construction of ophthalmic medical devices on January 7, 2020

Sinqi Ophthalmic Medications donated to the Sixth People’s Hospital of Shenyang for the fight against the epidemic on February 2, 2020

On February 4 and 17, 2020, Sinqi Ophthalmic Medications donated lysozyme eye drops to the Ophthalmology Society of Hubei Province and the medical team of Liaoning University of Traditional Chinese Medicine assigned to Xiangyang, respectively, to support the fight against the COVID-19 epidemic and strengthen the protection of frontline health workers.

The Organization Department of the Shenyang Municipal Party Committee and the Organization Department of the Hunnan District Party Committee visited Sinqi Ophthalmic Medications for inspection and guidance of epidemic prevention and control, work resumption and party building, etc. on March 12, 2020

The Party Working Committee of Gaokan Street, Hunnan District, Shenyang City visited Sinqi Ophthalmic Medications to inspect the party building and work resumption on April 29, 2020

A delegate of the Science and Technology Department of Liaoning Province visited Sinqi Ophthalmic Medications to inspect R & D and production, etc. in the morning of May 21, 2020

On February 14, 2020, Sinqi Ophthalmic Medications Shifude® Lutein Vitamin E Soft-gel Capsules obtained the domestic health food registration certificate from the State Administration for Market Regulations. The registration number is G20200164.

Sinqi Ophthalmic Medications received the notification of acceptance for the registration of sodium hyaluronate eye drops from the National Medical Products Administration on February 14, 2020

Sinqi Ophthalmic Medications donated to the China Children and Teenagers’ Fund in June 2020

Sinqi Ophthalmic Medications received the notification of acceptance for the registration of voriconazole eye drops from the National Medical Products Administration on June 18, 2020

Sinqi Ophthalmic Medications received the Drug Registration Approval Letter for cyclosporine eye drops (Ⅱ) from the National Medical Products Administration on June 22, 2020

Sinqi Ophthalmic Medications received the notification of acceptance for the registration of travoprost eye drops from the National Medical Products Administration on June 29, 2020

Sinqi Ophthalmic Medications established the Wenzhou Sinqi ophthalmology Life Science Co., Ltd., a wholly-owned subsidiary and completed the industrial and commercial registration formalities on June 29, 2020